Last reviewed · How we verify

NCT06209762

Investigation of the Effects of Inspiratory Muscle Training on Patients With Mechanical Low Back Pain.

Completed NA Last updated 8 July 2024
What this trial tests

NA trial testing Exercise in Mechanical Low Back Pain in 30 participants. Completed in 19 March 2024.

Timeline
26 December 2023
Primary endpoint
20 February 2024
19 March 2024

Quick facts

Lead sponsorYeditepe University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment30
Start date26 December 2023
Primary completion20 February 2024
Estimated completion19 March 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Yeditepe University

Who can join

Adults 18 to 65, any sex, with Mechanical Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There are many conservative treatment methods for the treatment of mechanical low back pain and they continue to be developed. The aim of this study is to examine the effects of inspiratory muscle training, which can be added to these treatment methods, on muscle endurance, functional capacity, pain intensity, disability, quality of life and sleep quality in people with mechanical low back pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Exercise

Trials testing the same drug.

Other recruiting trials for Mechanical Low Back Pain

Currently open trials in the same condition.

Other Yeditepe University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06209762.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing